ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 355,37
1,00%
Dow Jones
42 992,21
-0,77%
DAX
19 984,32
0,74%
Brent Oil
73,825
0,27%
Bitcoin
93 377,87
-0,15%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ABVC BioPharma Inc (ABVC) Cours

ABVC BioPharma Inc

ABVC BioPharma Inc (ABVC)

NASDAQ
0,5812
0,0222
(3,97%)
Fermé 30 Décembre 10:00PM
Retardé de 15 minutes
0,5813
0,0001
(0,02%)
Après les heures de négociation: 1:19AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,5813
Prix Achat
0,58
Prix Vente
0,684
Volume échangé
343 243
0,5502 Fourchette du Jour 0,629465
0,4053 Plage de 52 semaines 2,45
Cap du marché
7,543M
Clôture Veille
0,559
Ouverture
0,5502
Dernière Transaction
3
@
0.63
Dernière heure de transaction
Volume financier
US$ 206 758
VWAP
0,602365
Volume moyen (3 m)
267 832
Actions en circulation
12 975 492
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,74
Bénéfice par action (BPA)
-0,81
Chiffre d'affairess
152k
Bénéfice net
-10,52M

À propos de ABVC BioPharma Inc

ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved heal... ABVC BioPharma licenses promising medical research conducted in the Asia-Pacific region and enlists top-ranked principal investigators in the United States to conduct Phase II clinical trials. We specialize in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes that represent enormous commercial potential. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.abvcpharma.com
Siège social
Reno, Nevada, USA
Fondé
-
ABVC BioPharma Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ABVC. Le dernier cours de clôture d'ABVC BioPharma était de US$0,56. Au cours de la dernière année, les actions de ABVC BioPharma ont été négociées dans une fourchette de prix de US$ 0,4053 à US$ 2,45.

ABVC BioPharma compte actuellement 12 975 492 actions en circulation. La capitalisation boursière d'ABVC BioPharma est de US$7,25 million. ABVC BioPharma a un ratio cours/bénéfice (ratio PE) de -0.74.

ABVC Dernières nouvelles

Plus de nouvelles

ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21

FREMONT, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ophthalmology, CNS (central...

19 Décembre 2024
GlobeNewswire Inc.

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners

FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ophthalmology, CNS (central...

11 Décembre 2024
GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]

15 Novembre 2024
Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]

15 Novembre 2024
Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]

15 Novembre 2024
Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]

15 Novembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

15 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 Novembre 2024
Edgar (US Regulatory)

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones

ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received based on Executed Global Licensing Agreements that...

14 Novembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.073314.42913385830.5080.60.491159990.54156387CS
40.03937.250922509230.5420.60.42363919600.5176397CS
12-0.0587-9.1718750.640.770.40532678320.56824865CS
26-0.1397-19.37586685160.7210.9690.40531619450.61551875CS
52-0.6587-53.12096774191.242.450.40538070921.50591851CS
156-37.2187-98.462169312237.839.40.40536518503.33988302CS
260-32.6187-98.249096385533.2116.8830.405386109017.04296422CS

ABVC - Frequently Asked Questions (FAQ)

What is the current ABVC BioPharma share price?
The current share price of ABVC BioPharma is US$ 0,5813
How many ABVC BioPharma shares are in issue?
ABVC BioPharma has 12 975 492 shares in issue
What is the market cap of ABVC BioPharma?
The market capitalisation of ABVC BioPharma is USD 7,25M
What is the 1 year trading range for ABVC BioPharma share price?
ABVC BioPharma has traded in the range of US$ 0,4053 to US$ 2,45 during the past year
What is the PE ratio of ABVC BioPharma?
The price to earnings ratio of ABVC BioPharma is -0,74
What is the cash to sales ratio of ABVC BioPharma?
The cash to sales ratio of ABVC BioPharma is 51,28
What is the reporting currency for ABVC BioPharma?
ABVC BioPharma reports financial results in USD
What is the latest annual turnover for ABVC BioPharma?
The latest annual turnover of ABVC BioPharma is USD 152k
What is the latest annual profit for ABVC BioPharma?
The latest annual profit of ABVC BioPharma is USD -10,52M
What is the registered address of ABVC BioPharma?
The registered address for ABVC BioPharma is 401 RYLAND ST STE 200-A, RENO, RENO, NEVADA, 89502
What is the ABVC BioPharma website address?
The website address for ABVC BioPharma is www.abvcpharma.com
Which industry sector does ABVC BioPharma operate in?
ABVC BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INTZIntrusion Inc
US$ 2,167
(381,56%)
187,57M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
557,72M
HUBCWHub Cyber Security Ltd
US$ 0,035
(250,00%)
2,65M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,75M
LITMSnow Lake Resources Ltd
US$ 1,61
(82,95%)
129,92M
NEUPNeuphoria Therapeutics Inc
US$ 4,11
(-92,30%)
940,73k
VIRXViracta Therapeutics Inc
US$ 0,16
(-32,49%)
9,47M
PRFXPainReform Ltd
US$ 3,48
(-28,98%)
949,52k
AIREreAlpha Tech Corporation
US$ 2,56
(-28,49%)
8,42M
AVGRAvinger Inc
US$ 0,9721
(-24,05%)
2,16M
AILEiLearningEngines Inc
US$ 0,5932
(267,31%)
563,26M
GTIGraphjet Technology
US$ 0,967551
(185,83%)
398,95M
RGTIRigetti Computing Inc
US$ 17,08
(10,62%)
305,79M
XTIAXTI Aerospace Inc
US$ 0,03935
(-1,63%)
268M
QSIQuantum Si Inc
US$ 3,585
(66,74%)
256,01M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ABVC
ABVC BioPharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés